Deanna L. Kelly, PhD | Psychiatrist.com

Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al

Original Research

Clozapine Use in Patients with Benign Neutropenia

November 23, 2016

Is clozapine safe for patients with benign neutropenia? Many patients with lower than normal absolute neutrophil count do not qualify for clozapine therapy or are at risk of having...

Deanna L. Kelly, Robert P. McMahon, Charles M. Richardson, et al

Letter to the Editor

Substance Use and Cannabis Withdrawal

September 1, 2016

Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...

Deanna L. Kelly, Robert P. McMahon, Fang Liu, et al

Original Research

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study

January 12, 2010

Robert R. Conley, Raymond C. Love, Deanna L. Kelly, et al

Original Research

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

April 7, 2009

Dwight Dickinson, Robert R. Conley, Robert W. Buchanan, et al

Original Research

Clozapine Utilization and Outcomes by Race in a Public Mental Health System: 1994-2000

September 15, 2006

Robert R. Conley, Deborah Medoff, Clayton H. Brown, et al

Original Research

Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study

September 15, 2006

Robert R. Conley, Deanna L. Kelly, Joo-Cheol Shim, et al

Original Research

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

January 15, 2005

Robert R. Conley, Deanna L. Kelly

Letter to the Editor

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

September 1, 2003

Robert R. Conley, Julie Kreyenbuhl, Raymond C. Love, et al

Original Research

A Dose-Outcome Analysis of Risperidone

November 30, 1999

Robert R. Conley, Raymond C. Love, Deanna L. Kelly, et al